Almirall, S.A. (BME: ALM)

Market Cap	1.74B
Revenue (ttm)	953.49M
Net Income (ttm)	-44.87M
Shares Out	213.47M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	36.57
Dividend	0.18 (2.25%)
Ex-Dividend Date	n/a

Volume	125,032
Open	8.15
Previous Close	8.17
Day's Range	8.06 - 8.18
52-Week Range	7.85 - 10.04
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 24, 2025

About Almirall

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 1,904
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM